Global Shingles Vaccines Market Overview:
Global Shingles Vaccines Market Is Expected to Grow at A Significant Growth Rate, And the Forecast Period Is 2025-2032, Considering the Base Year As 2024.
Global Shingles Vaccines Market Report 2025 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2025-2032.This research study of Shingles Vaccines involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Shingles Vaccines Market:
The Shingles Vaccines Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Shingles Vaccines Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Shingles Vaccines Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Shingles Vaccines market has been segmented into:
Shingrix
Zostavax
and SKYZoster
By Application, Shingles Vaccines market has been segmented into:
Recombinant Vaccine and Live Attenuated Vaccine
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Shingles Vaccines market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Shingles Vaccines market.
Top Key Players Covered in Shingles Vaccines market are:
Merck & Co.
Inc.
Geneone Life Science
SK bioscience
GSK plc
Curevo Inc
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Industry Dynamics and Opportunity Analysis
3.1.1 Growth Drivers
3.1.2 Limiting Factors
3.1.3 Growth Opportunities
3.1.4 Challenges and Risks
3.2 Market Trend Analysis
3.3 Strategic Pestle Overview
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Mapping
3.6 Regulatory Framework
3.7 Princing Trend Analysis
3.8 Patent Analysis
3.9 Technology Evolution
3.10 Investment Pockets
3.11 Import-Export Analysis
Chapter 4: Shingles Vaccines Market Type
4.1 Shingles Vaccines Market Snapshot and Growth Engine
4.2 Shingles Vaccines Market Overview
4.3 Shingrix
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Shingrix: Geographic Segmentation Analysis
4.4 Zostavax
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Zostavax: Geographic Segmentation Analysis
4.5 and SKYZoster
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.5.3 and SKYZoster: Geographic Segmentation Analysis
Chapter 5: Shingles Vaccines Market Application
5.1 Shingles Vaccines Market Snapshot and Growth Engine
5.2 Shingles Vaccines Market Overview
5.3 Recombinant Vaccine and Live Attenuated Vaccine
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Recombinant Vaccine and Live Attenuated Vaccine: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Shingles Vaccines Market Share by Manufacturer (2023)
6.1.3 Concentration Ratio(CR5)
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 MERCK & CO.
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Operating Business Segments
6.2.5 Product Portfolio
6.2.6 Business Performance
6.2.7 Key Strategic Moves and Recent Developments
6.3 INC.
6.4 GENEONE LIFE SCIENCE
6.5 SK BIOSCIENCE
6.6 GSK PLC
6.7 CUREVO INC
Chapter 7: Global Shingles Vaccines Market By Region
7.1 Overview
7.2. North America Shingles Vaccines Market
7.2.1 Historic and Forecasted Market Size by Segments
7.2.2 Historic and Forecasted Market Size By Type
7.2.2.1 Shingrix
7.2.2.2 Zostavax
7.2.2.3 and SKYZoster
7.2.3 Historic and Forecasted Market Size By Application
7.2.3.1 Recombinant Vaccine and Live Attenuated Vaccine
7.2.4 Historic and Forecast Market Size by Country
7.2.4.1 US
7.2.4.2 Canada
7.2.4.3 Mexico
7.3. Eastern Europe Shingles Vaccines Market
7.3.1 Historic and Forecasted Market Size by Segments
7.3.2 Historic and Forecasted Market Size By Type
7.3.2.1 Shingrix
7.3.2.2 Zostavax
7.3.2.3 and SKYZoster
7.3.3 Historic and Forecasted Market Size By Application
7.3.3.1 Recombinant Vaccine and Live Attenuated Vaccine
7.3.4 Historic and Forecast Market Size by Country
7.3.4.1 Russia
7.3.4.2 Bulgaria
7.3.4.3 The Czech Republic
7.3.4.4 Hungary
7.3.4.5 Poland
7.3.4.6 Romania
7.3.4.7 Rest of Eastern Europe
7.4. Western Europe Shingles Vaccines Market
7.4.1 Historic and Forecasted Market Size by Segments
7.4.2 Historic and Forecasted Market Size By Type
7.4.2.1 Shingrix
7.4.2.2 Zostavax
7.4.2.3 and SKYZoster
7.4.3 Historic and Forecasted Market Size By Application
7.4.3.1 Recombinant Vaccine and Live Attenuated Vaccine
7.4.4 Historic and Forecast Market Size by Country
7.4.4.1 Germany
7.4.4.2 UK
7.4.4.3 France
7.4.4.4 The Netherlands
7.4.4.5 Italy
7.4.4.6 Spain
7.4.4.7 Rest of Western Europe
7.5. Asia Pacific Shingles Vaccines Market
7.5.1 Historic and Forecasted Market Size by Segments
7.5.2 Historic and Forecasted Market Size By Type
7.5.2.1 Shingrix
7.5.2.2 Zostavax
7.5.2.3 and SKYZoster
7.5.3 Historic and Forecasted Market Size By Application
7.5.3.1 Recombinant Vaccine and Live Attenuated Vaccine
7.5.4 Historic and Forecast Market Size by Country
7.5.4.1 China
7.5.4.2 India
7.5.4.3 Japan
7.5.4.4 South Korea
7.5.4.5 Malaysia
7.5.4.6 Thailand
7.5.4.7 Vietnam
7.5.4.8 The Philippines
7.5.4.9 Australia
7.5.4.10 New Zealand
7.5.4.11 Rest of APAC
7.6. Middle East & Africa Shingles Vaccines Market
7.6.1 Historic and Forecasted Market Size by Segments
7.6.2 Historic and Forecasted Market Size By Type
7.6.2.1 Shingrix
7.6.2.2 Zostavax
7.6.2.3 and SKYZoster
7.6.3 Historic and Forecasted Market Size By Application
7.6.3.1 Recombinant Vaccine and Live Attenuated Vaccine
7.6.4 Historic and Forecast Market Size by Country
7.6.4.1 Turkiye
7.6.4.2 Bahrain
7.6.4.3 Kuwait
7.6.4.4 Saudi Arabia
7.6.4.5 Qatar
7.6.4.6 UAE
7.6.4.7 Israel
7.6.4.8 South Africa
7.7. South America Shingles Vaccines Market
7.7.1 Historic and Forecasted Market Size by Segments
7.7.2 Historic and Forecasted Market Size By Type
7.7.2.1 Shingrix
7.7.2.2 Zostavax
7.7.2.3 and SKYZoster
7.7.3 Historic and Forecasted Market Size By Application
7.7.3.1 Recombinant Vaccine and Live Attenuated Vaccine
7.7.4 Historic and Forecast Market Size by Country
7.7.4.1 Brazil
7.7.4.2 Argentina
7.7.4.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Shingles Vaccines Scope:
|
Report Data
|
Shingles Vaccines Market
|
|
Shingles Vaccines Market Size in 2025
|
USD XX million
|
|
Shingles Vaccines CAGR 2025 - 2032
|
XX%
|
|
Shingles Vaccines Base Year
|
2024
|
|
Shingles Vaccines Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Merck & Co., Inc., Geneone Life Science, SK bioscience, GSK plc, Curevo Inc.
|
|
Key Segments
|
By Type
Shingrix
Zostavax
and SKYZoster
By Applications
Recombinant Vaccine and Live Attenuated Vaccine
|
